BackLakeShore Biopharma Co Overview

LakeShore Biopharma Co Common Stock

Latest common stock for YS: $29K.

Get informed when a big investor buys or sells

+ Follow
Common Stock
$28603.00
↑ 9.57% YoYΔ $2498.00 vs prior year quarter

Peer trimmed avg / median

Loading

LakeShore Biopharma Co Common Stock History

Loading

LakeShore Biopharma Co vs. peers: Common Stock Comparison

Loading

LakeShore Biopharma Co Common Stock Growth (YoY per quarter)

Latest change versus the prior comparable period (same company). Positive growth indicates new issuance/dilution; negative growth indicates reductions/buybacks.

Loading

LakeShore Biopharma Co (YS) FAQ

As of the most recent data (March 2025), YS shows a common stock of $29K. That compares with $26K in the prior-year period — up 9.6% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, YS's common stock is now $29K (was $26K) — a 9.6% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether LakeShore Biopharma Co is outperforming or lagging.

Tracking YS's common stock over time shows whether LakeShore Biopharma Co is scaling, shrinking, or reshaping that part of the business. The current reading is $29K That compares with $26K in the prior-year period — up 9.6% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this common stock page, Stockcircle has LakeShore Biopharma Co's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect common stock (currently $29K) with ownership activity and broader fundamentals.